Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
Targeted treatment of solid tumors and hematologic malignancies.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Adjuvant and metastatic treatment of postmenopausal women with Hormone Receptor-positive Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Treatment of anemia in cancer patients receiving concurrent myelosuppressive chemotherapy.
Prevention of skeletal-related events in patients with bone metastases from solid tumors and multiple myeloma; hypercalcemia of malignancy.
Adjuvant and metastatic treatment of postmenopausal women with Hormone Receptor-positive Breast Cancer.
Adjuvant and metastatic treatment of postmenopausal women with Hormone Receptor-positive Breast Cancer.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.